Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

miR-92b-3p Regulates Cell Cycle and Apoptosis by Targeting CDKN1C, Thereby Affecting the Sensitivity of Colorectal Cancer Cells to Chemotherapeutic Drugs

2 Jul 2021

Abstract excerpt

Colorectal cancer (CRC) is the third most common malignant tumor in the world and the second leading cause of cancer death. Multidrug resistance (MDR) has become a major obstacle in the clinical treatment of CRC. The clear molecular mechanism of MDR is complex, and miRNAs play an important role in drug resistance. This study used small RNAomic screens to analyze the expression profiles of miRNAs in CRC HCT8 cell...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Mechanisms and Therapy
Share to Circular RNAs in diseases
Share to MicroRNA in disease regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34283053
DOI: 10.3390/cancers13133323

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

miR-92b-3p Regulates Cell Cycle and Apoptosis by Targeting CDKN1C, Thereby Affecting the Sensitivity of Colorectal Cancer Cells to Chemotherapeutic DrugsPMID 34283053Read ↗

MicroRNA-Based Therapeutics for Drug-Resistant Colorectal CancerSemantic proximity Read ↗

Expression patterns of cell cycle and apoptosis‐related genes in a multidrug‐resistant human colon carcinoma cell lineSemantic proximity Read ↗

Mechanisms and Strategies to Overcome Drug Resistance in Colorectal CancerSemantic proximity Read ↗

Wnt/β‑catenin signaling: Causes and treatment targets of drug resistance in colorectal cancer (Review)Semantic proximity Read ↗

MicroRNAs as Regulators, Biomarkers and Therapeutic Targets in the Drug Resistance of Colorectal CancerSemantic proximity Read ↗

Strategies for overcoming ABC transporter-mediated multidrug resistance in colorectal cancerSemantic proximity Read ↗

MiR-200c Sensitizes Breast Cancer Cells to Carboplatin Treatment by Decreasing MDR1 ExpressionSemantic proximity Read ↗

Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancerSemantic proximity Read ↗

Portrayal of the complex molecular landscape of multidrug resistance in gastric cancer: Unveiling the potential targetsSemantic proximity Read ↗

Tumour suppressor genes in chemotherapeutic drug response.Semantic proximity Read ↗

miR-634 restores drug sensitivity in resistant ovarian cancer cells by targeting the Ras-MAPK pathwaySemantic proximity Read ↗

The lncRNA SCARNA2 mediates colorectal cancer chemoresistance through a conserved microRNA‐342‐3p target sequenceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.